Add to ORKGactivities of ofloxacin and ciprofloxacin. Mycobacterium tuberculosis compared with quinolone sparfloxacin (AT-4140) against In vitro activity of the new difluorinate
Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide range of bacteria. We te...
WOS: 000435396300005PubMed ID: 30020039Introduction: Increased tuberculosis prevalence, and isolatio...
The objective of this study was to determine the activities of rifampicin, ciprofloxacin and sparflo...
WOS: 000232812900009PubMed ID: 16270765BACKGROUND:The increasing incidence of drug-resistant Mycobac...
PubMed ID: 16270765Background: The increasing incidence of drug-resistant Mycobacterium tuberculosis...
WQ-3034 is a newly synthesized acidic fluoroquinolone. We assessed its in vitro activity against Myc...
New agents are urgently needed to meet the threat of multiple drug-resistant tuberculosis and to man...
BACKGROUND:The increasing incidence of drug-resistant Mycobacterium tuberculosis necessitates therap...
A set of 21 new fluoroquinolones bearing an aromatic or heteroaromatic moiety at C-7 and an alkyl gr...
tuberculosis. antituberculous drugs against Mycobacterium in combination with first- and second-line...
Tuberculosis continues to be a major cause of morbidity and mortality all over the world. Various 7-...
The susceptibility of 11 clinical isolates of Mycobacterium tuberculosis, 3 M. kansasii,3 M. xenopi,...
In tests with 18 drug-susceptible strains of Mycobacterium tuberculosis, the MIC at which 50 % of th...
Item does not contain fulltextFluoroquinolones (FQs) are important drugs to treat drug-resistant tub...
The in vitro activity of moxifloxacin, gatifloxacin, levofloxacin and linezolid was evaluated agains...
Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide range of bacteria. We te...
WOS: 000435396300005PubMed ID: 30020039Introduction: Increased tuberculosis prevalence, and isolatio...
The objective of this study was to determine the activities of rifampicin, ciprofloxacin and sparflo...
WOS: 000232812900009PubMed ID: 16270765BACKGROUND:The increasing incidence of drug-resistant Mycobac...
PubMed ID: 16270765Background: The increasing incidence of drug-resistant Mycobacterium tuberculosis...
WQ-3034 is a newly synthesized acidic fluoroquinolone. We assessed its in vitro activity against Myc...
New agents are urgently needed to meet the threat of multiple drug-resistant tuberculosis and to man...
BACKGROUND:The increasing incidence of drug-resistant Mycobacterium tuberculosis necessitates therap...
A set of 21 new fluoroquinolones bearing an aromatic or heteroaromatic moiety at C-7 and an alkyl gr...
tuberculosis. antituberculous drugs against Mycobacterium in combination with first- and second-line...
Tuberculosis continues to be a major cause of morbidity and mortality all over the world. Various 7-...
The susceptibility of 11 clinical isolates of Mycobacterium tuberculosis, 3 M. kansasii,3 M. xenopi,...
In tests with 18 drug-susceptible strains of Mycobacterium tuberculosis, the MIC at which 50 % of th...
Item does not contain fulltextFluoroquinolones (FQs) are important drugs to treat drug-resistant tub...
The in vitro activity of moxifloxacin, gatifloxacin, levofloxacin and linezolid was evaluated agains...
Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide range of bacteria. We te...
WOS: 000435396300005PubMed ID: 30020039Introduction: Increased tuberculosis prevalence, and isolatio...
The objective of this study was to determine the activities of rifampicin, ciprofloxacin and sparflo...